Unteka trading - Company finances
|
EUR
|
2022
From: 2022-09-07
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 4,667 | 14,483 | 180,706 | 389,112 |
| Profit before tax | - | -2,470 | 1,513 | - |
| Net profit | -1 | -2,470 | - | 331,429 |
| Equity | 2,500 | 29 | 1,539 | 2,500 |
| Liabilities | 2,639 | 11,628 | 93,396 | 267,674 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 5,139 | 11,657 | 94,935 | 270,174 |
| Total assets | 5,139 | 11,657 | 94,935 | 270,174 |
|
Taxes paid
|
||||
| STI taxes | - | 2,653 | 2,071 | 28,840 |
| Social insurance contributions | - | - | - | 3,033 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +210.3% | +1147.7% | +115.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -21.2% | - | 122.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -8517.2% | - | 13257.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | -17.1% | - | 85.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -17.1% | 0.8% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.1 | 401.0 | 60.7 | 107.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,667 | 11,586 | 94,280 | 145,915 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Unteka trading - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-13 | 0.04 |
| 2026-04-24 | 2026-04-29 | 0.04 |
| 2026-03-27 | 2026-03-27 | 15.24 |
| 2026-03-25 | 2026-03-25 | 20.68 |
| 2026-03-17 | 2026-03-24 | 15.24 |
| 2025-10-16 | 2025-10-26 | 7.38 |
| 2025-09-16 | 2025-09-24 | 12.57 |
| 2025-04-30 | 2025-04-30 | 11.66 |
| 2025-04-16 | 2025-04-24 | 11.66 |
| 2024-09-17 | 2024-09-30 | 174.07 |
| 2023-12-18 | 2023-12-28 | 387.90 |
| 2023-09-18 | 2023-09-28 | 39.03 |
| 2023-08-17 | 2023-09-03 | 119.11 |
| 2023-06-16 | 2023-06-19 | 170.16 |
| 2023-05-16 | 2023-06-01 | 161.65 |
| 2023-02-17 | 2023-02-20 | 170.16 |
| 2023-01-17 | 2023-01-31 | 178.67 |
Unteka trading - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-14 | 2025-04-26 | 12.22 |
| 2025-04-12 | 2025-04-13 | 304.22 |
| 2025-03-28 | 2025-04-11 | 6.22 |
| 2024-12-15 | 2024-12-28 | 1.78 |
| 2024-12-14 | 2024-12-14 | 1.39 |
| 2024-12-12 | 2024-12-13 | 94.94 |
| 2024-11-28 | 2024-12-11 | 0.94 |
| 2024-11-24 | 2024-11-25 | 0.94 |
| 2024-11-23 | 2024-11-23 | 0.28 |
| 2024-11-13 | 2024-11-22 | 123.62 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Unteka trading, UAB (Private Limited Liability Company, code 306122633) operates in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €389.1K, up 115.3% year on year and 2,586.7% over two years, indicating a rapid expansion in business volume. Net profit reached €331.4K, giving a very strong 85.2% profit margin. The company moved from a net loss of €2.5K in 2023 to a small pre-tax profit of €1.5K in 2024, and then to substantial profitability in 2025, showing a clear improvement in operating performance.
At the end of 2025, total assets were €270.2K, liabilities €267.7K and equity only €2.5K, which points to a highly leveraged balance sheet and a very small capital base, with equity representing 0.9% of assets. Asset turnover was 1.44x, while revenue per employee amounted to €194.6K and profit per employee to €165.7K, suggesting strong productivity in the latest year. Return measures were exceptionally elevated because of the very limited equity base.
At the end of 2025, total assets were €270.2K, liabilities €267.7K and equity only €2.5K, which points to a highly leveraged balance sheet and a very small capital base, with equity representing 0.9% of assets. Asset turnover was 1.44x, while revenue per employee amounted to €194.6K and profit per employee to €165.7K, suggesting strong productivity in the latest year. Return measures were exceptionally elevated because of the very limited equity base.